Tackling AI Hallucinations
Part 1 of 2 Analyze recent data on AI hallucination in healthcare, exploring its occurrence, implications, and strategies to mitigate associated risks.
Part 1 of 2 Analyze recent data on AI hallucination in healthcare, exploring its occurrence, implications, and strategies to mitigate associated risks.
An analysis of recent data on AI hallucination in healthcare, exploring its occurrence, implications, and strategies to mitigate associated risks.
Explore why hospital admissions spike during the holidays and what healthcare providers can do to manage the surge. From delayed care to seasonal illnesses and mental health challenges, this article dives into the data and offers actionable tips to improve outcomes and ease the strain on healthcare systems during the busiest time of year.
The American Hospital Association has opened applications for its second annual AHA Innovation Challenge.
Patients who stay in private rooms as opposed to double occupancy rooms have a reduced risk of central line infections, a hospital-acquired infection that causes thousands of deaths each year, a study published in PLOS ONE found.
New research released by WellCare Health Plans, Inc. and the University of South Florida (USF) College of Public Health, Tampa, and published in Population Health Management, reports that healthcare spending is substantially reduced when people are successfully connected to social services that address social barriers, or social determinants of health, such as secure housing, medical transportation, healthy food programs, and utility and financial assistance.
A report from Blue Cross Blue Shield Association, was released linking social determinants of health to differences in health across communities. From this report payers can see how demographic, behavioral, and structural factors impact health conditions of their members in different ways and gain greater insight into these differences to better understand population’s overall health.
CEOs at hospitals and health systems are faced with increasing headwinds as they look to move forward in an uncertain environment. So what are the key issues and trends CEOs are facing? Deloitte interviewed 20 health system CEOs this year to find out. While none of the key themes emerging from our interviews have really changed since Deloitte last spoke with health system CEOs, the urgency certainly has. Instead of thinking about these issues in a futuristic sense, CEOs are ready to address and tackle them now.
The purpose of this first annual surveillance report is to summarize the latest information available on the national level for various drug-related risks and health outcomes, health behaviors, and prescribing patterns related to the drug problem in the United States. The most recent year of information available is different for different outcomes. The emphasis is on national information, but some state information is also presented. This document is intended to serve as a resource for payers, providers, and pharma companies charged with addressing this ongoing national problem. It will be updated annually.
Currently, payer strategies focus on finding healthy populations, segmenting the markets, and segmenting populations, with the target of avoiding costly procedures. Population management and all the big data trends became useful tools in those payer strategies. With the results from a study by the Robert Wood Johnson Foundation and a position paper by America's Health Insurance Plans (AHIP), social determinants quickly rose as the next measurable data used by payers.